Elotuzumab

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (EH-loh-TOO-zoo-mab)

This page contains brief information about elotuzumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Empliciti
FDA Approved
Yes

FDA Approval for Elotuzumab

Use in Cancer

Elotuzumab is approved to be used with lenalidomide and dexamethasone to treat:

  • Multiple myeloma in patients who have already received one to three other types of treatment.

More About Elotuzumab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Elotuzumab - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Elotuzumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: December 8, 2015
  • Updated: February 5, 2016